Join the Oncology Voice Network. Join for Free
How to Architect a Presentation for an MSL Interview
Medical Science Liaisons MSL interview presentations virtual presentations crafting compelling narratives mastering Q&A session

How to Architect a Presentation for an MSL Interview


Share This Article


Summary

In this episode, Tom Caravela welcomes guests Kendra Peltz and Josh Yoder, who share their unique journeys from wrestling backgrounds to becoming Medical Science Liaisons. They delve into the intricacies of MSL interview presentations, offering insights on preparation and execution. Kendra discusses her approach to creating impactful presentations, while Josh shares tips on crafting compelling narratives. The conversation covers the importance of following interview instructions, choosing the right topics, and mastering the Q&A session. The episode wraps up with advice for virtual presentations and a preview of future topics, encouraging listeners to subscribe for more insights.

My guests today are Josh Yoder, Regional Director and Kendra Pelz, MSL at Syneos Health and we discuss how to "architect" a presentation for an MSL interview

Josh and Kendra share…

πŸ‘‰ Types of presentations companies typically request
πŸ‘‰ Summary of Kendra’s presentation process for her last interview
πŸ‘‰ A framework for an interview presentation
πŸ‘‰ Types of questions that can be expected during the Q&A portion
πŸ‘‰ Tips on how to stand out in your presentation

Click for Source
Medical Science Liaisons, MSL interview presentations, virtual presentations, crafting compelling narratives, mastering Q&A session

Related Topics

Meet Our Innovation Partners

Loading partners...

You May Also Like

Podcast
Social Media Listening Evolved
Partner Avatar MSL Talk: Tom Caravela, Conor McGladrigan, Kevin Peterson

Social Media Listening Evolved

Podcast
How to Start Presenting Like a Pro
Partner Avatar MSL Talk: Tom Caravela

How to Start Presenting Like a Pro

Article
Median Survival or Mean Survival: Which Measure Is the Most Appropriate for Patients, Physicians, and Policymakers?
OVN Avatar Omer Ben‐Aharon, Racheli Magnezi, Moshe Leshno, and Daniel A. Goldstein

Median Survival or Mean Survival: Which Measure Is the Most Appropriate for Patients, Physicians, and Policymakers?

Press Release
Announcing the Launch of Voices of Oncology: A Landmark Collaboration with Forbes
OVN Avatar OVN Staff

Announcing the Launch of Voices of Oncology: A Landmark Collaboration with Forbes

Press Release
Introducing OncologyVoiceNetwork.com
OVN Avatar OVN Staff

Introducing OncologyVoiceNetwork.com

Article
Updated estimates of eligibility for and response to genome-targeted oncology drugs among US cancer patients, 2006-2020
OVN Avatar A. Haslam, M.S. Kim, V. Prasad

Updated estimates of eligibility for and response to genome-targeted oncology drugs among US cancer patients, 2006-2020

Explore OVN